news
Adaptimmune and Universal Cells in T-cell therapy collaboration
1 December 2015 | By Victoria White
With Universal Cells’ proprietary gene editing technology, Adaptimmune intends to develop affinity enhanced donor T-cells...
List view / Grid view
Gene Therapy
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
news
UCL launches gene therapy company Athena Vision
24 November 2015 | By Kate Douetil
UCL has announced the formation of Athena Vision, a biopharmaceutical company focused on developing gene therapies for eye diseases...
news
Improved gene therapy shows promise in cystic fibrosis
16 November 2015 | By Victoria White
Scientists have reported an improved gene therapy treatment can cure mice with cystic fibrosis. Cell cultures also responded well to the treatment...
news
Regen BioPharma initiates NR2F6 T-cell immunotherapy preclinical studies
12 November 2015 | By Victoria White
The studies will evaluate the utilisation of NR2F6 gene silencing as a means of stimulating the immune system in cancer patients...
news
Scientists use dead C. sporogenes bacteria to kill cancer cells
10 November 2015 | By Victoria White
In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74%...
news
Scientists discover genetic cause and mechanism of noise-induced hearing loss
6 November 2015 | By Victoria White
The absence of pejvakin appears to be responsible for noise-induced hearing loss, one of the most common causes of deafness...
news
Possible solution for Alzheimer’s immunotherapy side effect
6 November 2015 | By Victoria White
Scientists have discovered that small changes in anti-amyloid antibodies preserves the immunotherapeutic activity without the inflammatory side effects...
news
Sanofi and BioNTech enter cancer immunotherapy collaboration
3 November 2015 | By Victoria White
The collaboration will leverage the scientific expertise of the two organisations to discover and develop up to five cancer immunotherapies...
news
Celyad awarded US patent covering allogeneic human primary T-Cells
26 October 2015 | By Victoria White
The US 9,181,527 Celyad Allogeneic Patent significantly strengthens Celyad’s patent portfolio in the CAR T-Cell field...
news
Gene therapy shows promise in retinitis pigmentosa
14 October 2015 | By Victoria White
Research has shown that gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa...
news
Asterias collaborates with Cell Therapy Catapult to scale production of AST-VAC2
13 October 2015 | By Victoria White
AST-VAC2 is an immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells...
news
Gene therapy prevents disease effects in Parkinson’s disease model
9 October 2015 | By Victoria White
Researchers reported that treatment with IFNβ-gene therapy successfully prevented neuronal death and disease effects in an experimental model of the disease...
news
Cell Therapy Catapult launches the Cell History File
7 October 2015 | By Victoria White
The Cell History File has been designed to fulfil the role of a ‘cell passport’ that can accompany a tissue or cell derived product as it progresses through various processing stages...
news
Gene therapy shows success in vision loss mitochondrial disease
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
article
Microfluidic technology: the next-generation drug discovery tool
Microfluidic miniaturisation, or the so-called ‘lab-on-a-chip’ concept, now encroaches on the fields of biology, medicine and pharmacology, and the nature of microfluidic technology (small volumes and high-throughput integration of fluid connections) means that it is outperforming conventional bench work. There has been an incredible need for microfluidic technology in the…
